<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Perrigo - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XpiZvApAIIQAAgcaUgAAAACA","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Perrigo","wgTitle":"Perrigo","wgCurRevisionId":946391808,"wgRevisionId":946391808,"wgArticleId":3095103,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Perrigo","wgRelevantArticleId":3095103,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,
"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q2916497","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":
"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.27"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f9/Perrigo_logo.svg/1200px-Perrigo_logo.svg.png"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Perrigo&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Perrigo&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Perrigo"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Perrigo rootpage-Perrigo stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Perrigo" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Perrigo" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Perrigo</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Perrigo" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Perrigo" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0">
<p class="mw-empty-elt">

</p>
<p><b>Perrigo Company plc</b> is an Irish–registered manufacturer of <a href="/wiki/Private_label" title="Private label">private label</a> <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter</a> <a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">pharmaceuticals</a>, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales.<sup id="cite_ref-sec_2-0" class="reference"><a href="#cite_note-sec-2">[2]</a></sup>  In 2013, Perrigo completed the 6th-largest U.S. <a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">corporate tax inversion</a> in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes.<sup id="cite_ref-bbb_3-0" class="reference"><a href="#cite_note-bbb-3">[3]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Perrigo Company plc</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Perrigo_logo.svg" class="image"><img alt="Perrigo logo.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f9/Perrigo_logo.svg/220px-Perrigo_logo.svg.png" decoding="async" width="220" height="82" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f9/Perrigo_logo.svg/330px-Perrigo_logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f9/Perrigo_logo.svg/440px-Perrigo_logo.svg.png 2x" data-file-width="512" data-file-height="191"></a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">public liability company</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:PRGO">PRGO</a><br><a href="/wiki/Tel_Aviv_Stock_Exchange" title="Tel Aviv Stock Exchange">TASE</a>: <a rel="nofollow" class="external text" href="http://www.tase.co.il/TASEEng/Management/GeneralPages/SimpleSearchResult.htm?objectId=&amp;objectType=&amp;securityType=&amp;searchTerm=PRGO">PRGO</a><br><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500 Component</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=IE00BGH1M568">IE00BGH1M568</a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">Pharmaceutical</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Predecessor</th><td style="line-height: 1.35em;">Perrigo Inc. (before the 2013 <a href="/wiki/Tax_inversion" title="Tax inversion">tax inversion</a> to Ireland)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1887<span class="noprint">; 133 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1887</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;">
<ul><li>(Legal) Hogan Place, <a href="/wiki/Dublin" title="Dublin">Dublin</a>, <a href="/wiki/Ireland" title="Ireland">Ireland</a></li>
<li>(Operational) <a href="/wiki/Allegan,_Michigan" title="Allegan, Michigan">Allegan, Michigan</a>, <a href="/wiki/United_States" title="United States">USA</a></li></ul></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Murray_S._Kessler" title="Murray S. Kessler">Murray S. Kessler</a>, President and CEO, Board Member</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">OTC</a>, RX, API, Medical Diagnostic, <a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">pharmaceuticals</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>3.540 billion  (<i>2013</i>)<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>805 million(<i>2013</i>)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/United_States_dollar" title="United States dollar">US$</a> 530 million (<i>2013</i>)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">10,220 (<i>May 2015</i>)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Subsidiary" title="Subsidiary">Subsidiaries</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/Omega_Pharma" title="Omega Pharma">Omega Pharma</a></li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://perrigo.com">perrigo<wbr></wbr>.com</a></span></td></tr></tbody></table><p>Perrigo engages in the acquisition (for repricing), manufacture, and sale of consumer healthcare products, generic prescription drugs, and <a href="/wiki/Active_pharmaceutical_ingredient" class="mw-redirect" title="Active pharmaceutical ingredient">active pharmaceutical ingredients</a> (APIs), primarily in the <a href="/wiki/United_States" title="United States">United States</a>, from its base in Ireland.  On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish <a href="/wiki/Revenue_Commissioners" title="Revenue Commissioners">Revenue Commissioners</a> issued a tax claim against Perrigo that equated to half of its market value.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup><sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup></p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#Acquisitions"><span class="tocnumber">1.1</span> <span class="toctext">Acquisitions</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Acquisition_history"><span class="tocnumber">1.2</span> <span class="toctext">Acquisition history</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-4"><a href="#Segments"><span class="tocnumber">2</span> <span class="toctext">Segments</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#See_also"><span class="tocnumber">3</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#Corporate_tax_inversions" title="Corporation tax in the Republic of Ireland">Corporation tax in the Republic of Ireland § Corporate tax inversions</a></div>
<p><b>L. Perrigo Company</b> was founded in 1887 in <a href="/wiki/Allegan,_Michigan" title="Allegan, Michigan">Allegan, Michigan</a>, by Luther and Charles Perrigo, who ran a general store.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup></p><p>In 1991 Perrigo had an <a href="/wiki/Initial_public_offering" title="Initial public offering">initial public offering</a> on <a href="/wiki/NASDAQ" class="mw-redirect" title="NASDAQ">NASDAQ</a>.
</p><p>In March 2005 the firm acquired Agis Industries Limited (<a href="/wiki/Tel_Aviv_Stock_Exchange" title="Tel Aviv Stock Exchange">TASE</a>:AGIS), an Israel-based <a href="/wiki/Generic_pharmaceuticals" class="mw-redirect" title="Generic pharmaceuticals">generic pharmaceuticals</a> company in an $850 million transaction. Agis was founded in 1983 by <a href="/wiki/Mori_Arkin" title="Mori Arkin">Mori Arkin</a> who developed his father's small drug import business into a multinational generic pharmaceutical company. As a result of the acquisition, Arkin owned 9% of Perrigo, and was appointed as Vice Chairman of the company.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup></p><p>In July 2013, Perrigo announced that it would execute a <a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">corporate tax inversion</a> to Ireland in order to avoid U.S. corporate taxes, via an $8.6 billion acquisition of Irish-based <a href="/wiki/%C3%89lan" title="Élan">Elan Corporation</a>.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup>  As of November 2018<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Perrigo&amp;action=edit">[update]</a></sup>, Perrigo is the 6th-largest U.S. tax inversion in history.<sup id="cite_ref-medtronic_9-0" class="reference"><a href="#cite_note-medtronic-9">[9]</a></sup><sup id="cite_ref-wplist_10-0" class="reference"><a href="#cite_note-wplist-10">[10]</a></sup><sup id="cite_ref-bbb_3-1" class="reference"><a href="#cite_note-bbb-3">[3]</a></sup>  Over 70% of Perrigo's sales, and an even greater percentage of Perrigo profits, are from the U.S. healthcare system.<sup id="cite_ref-forbesinversion_11-0" class="reference"><a href="#cite_note-forbesinversion-11">[11]</a></sup><sup id="cite_ref-sec_2-1" class="reference"><a href="#cite_note-sec-2">[2]</a></sup></p><p>In April 2015, Perrigo received an unsolicited buy-out offer from <a href="/wiki/Mylan" title="Mylan">Mylan</a> of $29 billion, which was ultimately rejected by management and shareholders.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup> In May 2016, Perrigo investors sued the company over statements made during the Mylan bid,<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup> which were said to have persuaded shareholders to vote against the deal.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">[14]</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup> In the months prior to this suit, the company's chairman and CEO, <a href="/wiki/Joseph_C._Papa" title="Joseph C. Papa">Joseph Papa</a>, who has been credited with "fending off" Mylan's bid, left to take the CEO role at Valeant.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">[16]</a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17">[17]</a></sup> Upon Papa's departure, <a href="/wiki/John_Hendrickson_(businessman)" title="John Hendrickson (businessman)">John Hendrickson</a>, who was at the time the company's president, took on the additional roles of chairman and CEO.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup> Hendrickson was succeeded by Uwe Roehrhoff in January, 2018.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup> Murray S. Kessler is the current President and CEO.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup></p><p>On 20 December 2018, the <i><a href="/wiki/Financial_Times" title="Financial Times">Financial Times</a></i> reported that the Irish <a href="/wiki/Revenue_Commissioners" title="Revenue Commissioners">Revenue Commissioners</a> levied a €1.64 billion (not including penalties and interest) Irish tax claim on Perrigo for unpaid capital gains tax (CGT) from the 2013 sale of <a href="/wiki/Tysabri" class="mw-redirect" title="Tysabri">Tysabri</a> to <a href="/wiki/Biogen" title="Biogen">Biogen</a> by Elan, which happened months before Perrigo's acquisition of Elan.<sup id="cite_ref-ft_22-0" class="reference"><a href="#cite_note-ft-22">[22]</a></sup>  The claim is the second largest ever issued by the Revenue Commissioners in Irish history, after <a href="/wiki/EU_illegal_State_aid_case_against_Apple_in_Ireland" title="EU illegal State aid case against Apple in Ireland">Apple's €13 billion Irish tax fine</a>.<sup id="cite_ref-ft_22-1" class="reference"><a href="#cite_note-ft-22">[22]</a></sup>  On 21 December 2018, the <i><a href="/wiki/Irish_Times" class="mw-redirect" title="Irish Times">Irish Times</a></i> reported that Revenue claimed Perrigo owed CGT at a rate of 33% as an "asset sale", however Perrigo claimed that the sale was part of Elan's normal "trading income", and was subject to the lower 12.5% Irish corporate tax rate, which Perrigo was able to reduce to 0% using Ireland's <i><a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#Multinational_tax_schemes" title="Corporation tax in the Republic of Ireland">multinational tax BEPS tools</a></i>.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Acquisitions">Acquisitions</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=2" title="Edit section: Acquisitions" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>On 9 January 2008, the firm acquired <a href="/wiki/Galpharm_International" title="Galpharm International">Galpharm Healthcare, Ltd.</a>, a supplier of <a href="/wiki/Over-the-counter" class="mw-redirect" title="Over-the-counter">over-the-counter</a> store brand pharmaceuticals in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup> On 16 September 2008, the firm acquired J.B. Laboratories.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup> On 6 October 2008, it acquired Laboratorios Diba S.A., enabling the company to market its products in  Mexico.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup> On 13 November 2008, it acquired Unico Holdings, a manufacturer of store brand pediatric electrolytes, enemas and feminine hygiene products for retail consumers in the U.S.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup></p><p>On 1 March 2010, the firm acquired Orion Laboratories Pty, Ltd., a supplier of <a href="/wiki/Over-the-counter" class="mw-redirect" title="Over-the-counter">over-the-counter</a> (OTC) store brand pharmaceutical products in Australia and New Zealand.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup> On 23 March 2010, it acquired PBM Holdings, Inc., a producer of over-the-counter store brand <a href="/wiki/Infant_formula" title="Infant formula">infant formula</a> and baby foods in the United States, Canada, Mexico and China.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup></p><p>On 20 January 2011, the firm announced that it would acquire Paddock Laboratories Inc., with the deal expected to close in fiscal 2012.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup></p><p>In September 2012, Perrigo announced its intention to enter the animal wellness category by acquiring the assets of Sergeant's Pet Care Products, Inc., a privately held manufacturer of over-the-counter companion animal healthcare products.<sup id="cite_ref-Sergeant's_Pet_Care_Acquisition_31-0" class="reference"><a href="#cite_note-Sergeant's_Pet_Care_Acquisition-31">[31]</a></sup></p><p>On 11 February 2013, Perrigo announced the completion of the acquisition of Rosemont Pharmaceuticals Ltd., a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations.<sup id="cite_ref-Rosemont_acqusition_32-0" class="reference"><a href="#cite_note-Rosemont_acqusition-32">[32]</a></sup></p><p>On 29 July 2013, the firm announced that it would acquire <a href="/wiki/%C3%89lan" title="Élan">Élan</a>, a pharmaceutical firm based in Dublin.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup> The Élan acquisition enabled Perrigo to reincorporate as an Irish company using Élan's headquarters (although the executive offices remained in Allegan), lowering its effective tax rate (called a <a href="/wiki/Tax_inversion" title="Tax inversion">tax inversion</a>).<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup></p><p>In November 2014, Perrigo announced it had agreed to buy Belgian health-products provider <a href="/wiki/Omega_Pharma" title="Omega Pharma">Omega Pharma</a> approximately $4.5 billion (€3.6 billion).<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">[36]</a></sup><sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup> The transaction was completed in March 2015.<sup id="cite_ref-complete_38-0" class="reference"><a href="#cite_note-complete-38">[38]</a></sup></p><p>In August 2016, the company announced it would acquire US national distributor of over-the-counter medicines, Geiss, Destin &amp; Dunn<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup></p><p>In May 2019, Perrigo announced it would acquire Ranir Global Holdings LLC, boosting its oral self-care offering, with the transaction valued at $750 million.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup></p><p>In February 2020, announced that it has reached an agreement to acquire the oral care assets of High Ridge Brands for $113 million.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup><sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Acquisition_history">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=3" title="Edit section: Acquisition history" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
</p>
<style data-mw-deduplicate="TemplateStyles:r935768785">.mw-parser-output table.clade{border-spacing:0;margin:0;font-size:100%;line-height:100%;border-collapse:separate;width:auto}.mw-parser-output table.clade table.clade{width:100%}.mw-parser-output table.clade td.clade-label{width:0.7em;padding:0 0.15em;vertical-align:bottom;text-align:center;border-left:1px solid;border-bottom:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-fixed-width{overflow:hidden;text-overflow:ellipsis}.mw-parser-output table.clade td.clade-fixed-width:hover{overflow:visible}.mw-parser-output table.clade td.clade-label.first{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-label.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-slabel{padding:0 0.15em;vertical-align:top;text-align:center;border-left:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-slabel:hover{overflow:visible}.mw-parser-output table.clade td.clade-slabel.last{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-slabel.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-bar{vertical-align:middle;text-align:left;padding:0 0.5em;position:relative}.mw-parser-output table.clade td.clade-bar.reverse{text-align:right;position:relative}.mw-parser-output table.clade td.clade-leaf{border:0;padding:0;text-align:left}.mw-parser-output table.clade td.clade-leafR{border:0;padding:0;text-align:right}.mw-parser-output table.clade td.clade-leaf.reverse{text-align:right}.mw-parser-output table.clade:hover span.linkA{background-color:yellow}.mw-parser-output table.clade:hover span.linkB{background-color:green}</style><table class="clade" style="font-size:90%;line-height:110%"><tbody><tr><td class="clade-label first" style="border-left:none;border-right:none;border-bottom:0px solid;"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"><b>Perrigo</b>
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Geiss, Proteon Therapeutics<br><small>(Acq 2016)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Geiss, Destin &amp; Dunn<br><small>(Acq 2016)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p><a href="/wiki/Omega_Pharma" title="Omega Pharma">Omega Pharma</a><br><small>(Acq 2015)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p><a href="/wiki/%C3%89lan" title="Élan">Élan</a><br><small>(Acq 2013)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Rosemont Pharmaceuticals Ltd<br><small>(Acq 2013)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Sergeant's Pet Care Products Inc<br><small>(Acq 2012)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Paddock Laboratories Inc<br><small>(Acq 2011)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>PBM Holdings Inc<br><small>(Acq 2010)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Orion Laboratories Pty Ltd<br><small>(Acq 2010)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Unico Holdings<br><small>(Acq 2008)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Laboratorios Diba S.A.<br><small>(Acq 2008)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>J.B. Laboratories<br><small>(Acq 2008)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Galpharm International<br><small>(Acq 2008)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>Agis Industries Ltd <br><small>(Acq 2005)</small>
</p>
</td></tr><tr><td class="clade-slabel"> 
</td></tr><tr><td class="clade-label"> 
</td>
<td rowspan="2" class="clade-leaf">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td class="clade-label first"> 
</td>
<td rowspan="2" class="clade-leaf">
<p>L. Perrigo Company <br><small>(Founded 1887)</small>
</p>
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td></tr><tr><td class="clade-slabel last" style="border-right:none;border-left:none;"> 
</td></tr></tbody></table></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Segments">Segments</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=4" title="Edit section: Segments" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>The company operates in three segments; Consumer Self-care Americas, Rx Pharmaceuticals, and Consumer Self-Care International. The Consumer Self-care Americas segment produces over-the-counter pharmaceutical and nutritional products in the United States, the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, and Mexico. This segment offers <a href="/wiki/Analgesic" title="Analgesic">analgesic</a>, cough/cold/allergy/sinus, gastrointestinal, <a href="/wiki/Smoking_cessation" title="Smoking cessation">smoking cessation</a>, <a href="/wiki/First_aid" title="First aid">first aid</a>, antacids, hemorrhoidal remedies, motion sickness, sleep aid products, feminine hygiene products, vitamin, and <a href="/wiki/Nutritional_supplement" class="mw-redirect" title="Nutritional supplement">nutritional supplement</a> products.
</p><p>The Rx Pharmaceuticals segment produces generic prescription drugs   in the United States. This segment provides creams, ointments, lotions, gels, and solutions, as well as nasal sprays, foams, and <a href="/wiki/Transdermal" title="Transdermal">transdermal</a> devices. Believing that Rx business has the potential to realize greater value outside of Perrigo, board okays separation of prescription pharma business on 9 August 2018.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup></p><p>The Consumer Self-Care International (CSCI) segment develops, manufactures, markets, and distributes well-known European self-care brands in the natural health and vitamins, cough, cold and allergy, oral care, smoking cessation, personal care and derma-therapeutics and lifestyle categories.
</p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=5" title="Edit section: See also" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<ul><li><a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#Corporate_tax_inversions" title="Corporation tax in the Republic of Ireland">Corporate tax inversions</a></li>
<li><a href="/wiki/Ireland_as_a_tax_haven" title="Ireland as a tax haven">Ireland as a tax haven</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=6" title="Edit section: References" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references"><li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><cite class="citation news">Jones, Al (16 August 2011). <a rel="nofollow" class="external text" href="http://www.mlive.com/business/west-michigan/index.ssf/2011/08/perrigo_co_reports_strong_gain.html">"Perrigo Co. reports strong gains in sales and earnings for fourth quarter and full year"</a>. <i><a href="/wiki/Mlive.com" class="mw-redirect" title="Mlive.com">Mlive.com</a></i>. <a href="/wiki/Allegan,_Michigan" title="Allegan, Michigan">Allegan</a>. <a href="/wiki/Kalamazoo_Gazette" title="Kalamazoo Gazette">Kalamazoo Gazette</a><span class="reference-accessdate">. Retrieved <span class="nowrap">20 August</span> 2011</span>. <q>Sales for the full year were $2.75 billion, up about 21.5 percent from $2.26 billion in fiscal 2010.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mlive.com&amp;rft.atitle=Perrigo+Co.+reports+strong+gains+in+sales+and+earnings+for+fourth+quarter+and+full+year&amp;rft.date=2011-08-16&amp;rft.aulast=Jones&amp;rft.aufirst=Al&amp;rft_id=http%3A%2F%2Fwww.mlive.com%2Fbusiness%2Fwest-michigan%2Findex.ssf%2F2011%2F08%2Fperrigo_co_reports_strong_gain.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-sec-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-sec_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-sec_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book"><i>Perrigo Co plc: Form 10-Q (29 September 2018)</i>. <a href="/wiki/Securities_and_Exchange_Commission" class="mw-redirect" title="Securities and Exchange Commission">Securities and Exchange Commission</a>. 8 November 2018. p. 9. <q>Disaggregation of Revenue</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Perrigo+Co+plc%3A+Form+10-Q+%2829+September+2018%29&amp;rft.pages=9&amp;rft.pub=Securities+and+Exchange+Commission&amp;rft.date=2018-11-08&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-bbb-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-bbb_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bbb_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/graphics/tax-inversion-tracker/">"Tracking Tax Runaways"</a>. <a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a>. 1 March 2017. <q>Bloomberg Special Reports: Corporate Tax Inversions</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Tracking+Tax+Runaways&amp;rft.pub=Bloomberg+News&amp;rft.date=2017-03-01&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fgraphics%2Ftax-inversion-tracker%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation web">Cantillion (21 December 2018). <a rel="nofollow" class="external text" href="https://www.irishtimes.com/business/health-pharma/the-terrible-irony-of-perrigo-s-tax-planning-1.3739781">"The terrible irony of Perrigo's tax planning"</a>. <a href="/wiki/Irish_Times" class="mw-redirect" title="Irish Times">Irish Times</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+terrible+irony+of+Perrigo%E2%80%99s+tax+planning&amp;rft.pub=Irish+Times&amp;rft.date=2018-12-21&amp;rft.au=Cantillion&amp;rft_id=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Fhealth-pharma%2Fthe-terrible-irony-of-perrigo-s-tax-planning-1.3739781&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation web">Charly Grant (21 December 2018). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/perrigo-tax-shocker-couldnt-come-at-worse-time-11545408948">"Perrigo Tax Shocker Couldn't Come at Worse Time"</a>. Wall Street Journal.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Perrigo+Tax+Shocker+Couldn%E2%80%99t+Come+at+Worse+Time&amp;rft.pub=Wall+Street+Journal&amp;rft.date=2018-12-21&amp;rft.au=Charly+Grant&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fperrigo-tax-shocker-couldnt-come-at-worse-time-11545408948&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation"><a rel="nofollow" class="external text" href="http://www.fundinguniverse.com/company-histories/Perrigo-Company-Company-History.html">"Perrigo Company - Company History"</a>, <i>Funding Universe</i><span class="reference-accessdate">, retrieved <span class="nowrap">31 October</span> 2009</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Funding+Universe&amp;rft.atitle=Perrigo+Company+-+Company+History&amp;rft_id=http%3A%2F%2Fwww.fundinguniverse.com%2Fcompany-histories%2FPerrigo-Company-Company-History.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20061025235552/http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/news_ir_114.11.15%20Perrigo%20to%20Acquire%20Agis.pdf">"Perrigo Company to Acquire Agis Industries, Creating A Leading Diversified Healthcare Company"</a> <span class="cs1-format">(PDF)</span> (Press release). Company press release. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/news_ir_114.11.15%20Perrigo%20to%20Acquire%20Agis.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 25 October 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">31 October</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Perrigo+Company+to+Acquire+Agis+Industries%2C+Creating+A+Leading+Diversified+Healthcare+Company&amp;rft.pub=Company+press+release&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2Fnews_ir_114.11.15%2520Perrigo%2520to%2520Acquire%2520Agis.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/elan/update-4-u-s-drugmaker-perrigo-to-buy-irelands-elan-for-8-6-bln-idUSL6N0FZ0MY20130729">"UPDATE 4-U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 bln"</a>. Reuters. 29 July 2013. <q>DUBLIN, July 29, 2013 (Reuters) - U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UPDATE+4-U.S.+drugmaker+Perrigo+to+buy+Ireland%27s+Elan+for+%248.6+bln&amp;rft.pub=Reuters&amp;rft.date=2013-07-29&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Felan%2Fupdate-4-u-s-drugmaker-perrigo-to-buy-irelands-elan-for-8-6-bln-idUSL6N0FZ0MY20130729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-medtronic-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-medtronic_9-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Emily Stewart (22 July 2017). <a rel="nofollow" class="external text" href="https://www.thestreet.com/slideshow/14222919/1/as-treasury-moves-to-bring-back-inversions-here-are-seven-of-the-biggest-recent-deals.html">"As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals"</a>. TheStreet.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=As+Treasury+Moves+to+Bring+Back+Inversions%2C+Here+are+7+of+the+Biggest+Recent+Deals&amp;rft.pub=TheStreet&amp;rft.date=2017-07-22&amp;rft.au=Emily+Stewart&amp;rft_id=https%3A%2F%2Fwww.thestreet.com%2Fslideshow%2F14222919%2F1%2Fas-treasury-moves-to-bring-back-inversions-here-are-seven-of-the-biggest-recent-deals.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wplist-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-wplist_10-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Danielle Douglas-Gabriel (6 August 2014). <a rel="nofollow" class="external text" href="https://www.washingtonpost.com/news/wonk/wp/2014/08/06/these-are-the-companies-abandoning-the-u-s-to-dodge-taxes/?noredirect=on">"These are the companies abandoning the U.S. to dodge taxes"</a>. The Washington Post.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=These+are+the+companies+abandoning+the+U.S.+to+dodge+taxes&amp;rft.pub=The+Washington+Post&amp;rft.date=2014-08-06&amp;rft.au=Danielle+Douglas-Gabriel&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fnews%2Fwonk%2Fwp%2F2014%2F08%2F06%2Fthese-are-the-companies-abandoning-the-u-s-to-dodge-taxes%2F%3Fnoredirect%3Don&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-forbesinversion-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-forbesinversion_11-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Janet Novack (10 September 2014). <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/janetnovack/2014/09/10/the-tax-inversion-rush-in-one-handy-graphic/#4b2eac18bf02">"The Tax Inversion Rush: One Handy Graphic"</a>. <a href="/wiki/Forbes_Magazine" class="mw-redirect" title="Forbes Magazine">Forbes Magazine</a>. <q>The U.S. company is in black, as is the share of the merged company its current shareholders will own; it must be less than 80% for the tax trick to work under the current law.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Tax+Inversion+Rush%3A+One+Handy+Graphic&amp;rft.pub=Forbes+Magazine&amp;rft.date=2014-09-10&amp;rft.au=Janet+Novack&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjanetnovack%2F2014%2F09%2F10%2Fthe-tax-inversion-rush-in-one-handy-graphic%2F%234b2eac18bf02&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2015/04/08/us-perrigo-company-m-a-mylan-idUSKBN0MZ1OX20150408">"Generic drugmaker Mylan offers $29 billion for Perrigo"</a> (Press release). Reuters. 8 April 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Generic+drugmaker+Mylan+offers+%2429+billion+for+Perrigo&amp;rft.pub=Reuters&amp;rft.date=2015-04-08&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2015%2F04%2F08%2Fus-perrigo-company-m-a-mylan-idUSKBN0MZ1OX20150408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.bna.com/investor-sues-perrigo-n57982072957/">"Investor Sues Perrigo Over Disclosures in Mylan Hostile Bid"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Investor+Sues+Perrigo+Over+Disclosures+in+Mylan+Hostile+Bid&amp;rft_id=http%3A%2F%2Fwww.bna.com%2Finvestor-sues-perrigo-n57982072957%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.bizjournals.com/pittsburgh/news/2016/05/24/lawsuit-filed-against-former-mylan-acquisition.html">"Lawsuit filed against former Mylan acquisition target Perrigo - Pittsburgh Business Times"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lawsuit+filed+against+former+Mylan+acquisition+target+Perrigo+-+Pittsburgh+Business+Times&amp;rft_id=http%3A%2F%2Fwww.bizjournals.com%2Fpittsburgh%2Fnews%2F2016%2F05%2F24%2Flawsuit-filed-against-former-mylan-acquisition.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.law360.com/articles/818827/perrigo-investor-slams-co-over-mylan-s-failed-takeover">"Perrigo Investor Slams Co. Over Mylan's Failed Takeover - Law360"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Perrigo+Investor+Slams+Co.+Over+Mylan%27s+Failed+Takeover+-+Law360&amp;rft_id=http%3A%2F%2Fwww.law360.com%2Farticles%2F818827%2Fperrigo-investor-slams-co-over-mylan-s-failed-takeover&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation news">Lopez, Linette (28 April 2016). <a rel="nofollow" class="external text" href="http://uk.businessinsider.com/valeant-new-ceo-pay-package-2016-4">"Now we know why Valeant's new CEO took the job, and it seems politicians are upset about it"</a>. <i>Business Insider UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider+UK&amp;rft.atitle=Now+we+know+why+Valeant%27s+new+CEO+took+the+job%2C+and+it+seems+politicians+are+upset+about+it&amp;rft.date=2016-04-28&amp;rft.aulast=Lopez&amp;rft.aufirst=Linette&amp;rft_id=http%3A%2F%2Fuk.businessinsider.com%2Fvaleant-new-ceo-pay-package-2016-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><cite class="citation journal">Wright, Rob (9 January 2018). <span class="cs1-lock-limited" title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" class="external text" href="https://www.lifescienceleader.com/doc/can-joseph-papa-save-valeant-0001">"Can Joseph Papa Save Valeant?"</a></span>. <i>Life Science Leader</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Life+Science+Leader&amp;rft.atitle=Can+Joseph+Papa+Save+Valeant%3F&amp;rft.date=2018-01-09&amp;rft.aulast=Wright&amp;rft.aufirst=Rob&amp;rft_id=https%3A%2F%2Fwww.lifescienceleader.com%2Fdoc%2Fcan-joseph-papa-save-valeant-0001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation news">Helfand, Carley (6 June 2017). <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/perrigo-ceo-hendrickson-to-depart-after-rocky-13-month-turn-at-top">"Floundering Perrigo's CEO Hendrickson to depart after rocky 13-month tenure"</a>. <i>FiercePharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Floundering+Perrigo%27s+CEO+Hendrickson+to+depart+after+rocky+13-month+tenure&amp;rft.date=2017-06-06&amp;rft.aulast=Helfand&amp;rft.aufirst=Carley&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fperrigo-ceo-hendrickson-to-depart-after-rocky-13-month-turn-at-top&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.ibtimes.com/valeant-joseph-papa-joins-pharmaceutical-company-chief-exec-perrigo-names-hendrickson-2359026">"Valeant: Joseph Papa Joins Pharmaceutical Company As Chief Exec As Perrigo Names Hendrickson New CEO"</a>. <i>International Business Times</i>. 25 April 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Business+Times&amp;rft.atitle=Valeant%3A+Joseph+Papa+Joins+Pharmaceutical+Company+As+Chief+Exec+As+Perrigo+Names+Hendrickson+New+CEO&amp;rft.date=2016-04-25&amp;rft_id=http%3A%2F%2Fwww.ibtimes.com%2Fvaleant-joseph-papa-joins-pharmaceutical-company-chief-exec-perrigo-names-hendrickson-2359026&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-perrigo-company-ceo-idUSKBN1EX0GR">"Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO"</a>. 8 January 2018 – via www.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Perrigo+hires+Gerresheimer+ex-boss+Rohrhoff+as+new+CEO&amp;rft.date=2018-01-08&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-perrigo-company-ceo-idUSKBN1EX0GR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://investor.perrigo.com/2018-10-08-Perrigo-Appoints-Murray-S-Kessler-As-President-And-Chief-Executive-Officer-In-Line-With-Shift-To-Consumer-Focused-Strategy">"Press Releases"</a>. <i>Perrigo InvestorRoom</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Perrigo+InvestorRoom&amp;rft.atitle=Press+Releases&amp;rft_id=https%3A%2F%2Finvestor.perrigo.com%2F2018-10-08-Perrigo-Appoints-Murray-S-Kessler-As-President-And-Chief-Executive-Officer-In-Line-With-Shift-To-Consumer-Focused-Strategy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-ft-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-ft_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ft_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Authur Beesley (20 December 2018). <a rel="nofollow" class="external text" href="https://www.ft.com/content/c72affc0-04a4-11e9-99df-6183d3002ee1">"Drugs group Perrigo hit with €1.64bn Irish back tax bill"</a>. <a href="/wiki/Financial_Times" title="Financial Times">Financial Times</a>. <q>The tax assessment is Ireland’s largest since the European Commission directed Apple to pay €14.3bn in disputed back taxes to Dublin in a record-breaking ruling that the Irish authorities have taken to the European courts for an appeal.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drugs+group+Perrigo+hit+with+%E2%82%AC1.64bn+Irish+back+tax+bill&amp;rft.pub=Financial+Times&amp;rft.date=2018-12-20&amp;rft.au=Authur+Beesley&amp;rft_id=https%3A%2F%2Fwww.ft.com%2Fcontent%2Fc72affc0-04a4-11e9-99df-6183d3002ee1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web">Cliff Taylor (21 December 2018). <a rel="nofollow" class="external text" href="https://www.irishtimes.com/business/health-pharma/what-s-the-massive-perrigo-tax-bill-all-about-1.3739350">"What's the massive Perrigo tax bill all about?"</a>. <a href="/wiki/Irish_Times" class="mw-redirect" title="Irish Times">Irish Times</a>. <q>A twist is that Elan used accumulated losses to avoid paying any up-front tax bill at the time on the initial payment from Biogen.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=What%E2%80%99s+the+massive+Perrigo+tax+bill+all+about%3F&amp;rft.pub=Irish+Times&amp;rft.date=2018-12-21&amp;rft.au=Cliff+Taylor&amp;rft_id=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Fhealth-pharma%2Fwhat-s-the-massive-perrigo-tax-bill-all-about-1.3739350&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20111009135258/http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/PRGOPR(11).pdf">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/PRGOPR(11).pdf">the original</a> <span class="cs1-format">(PDF)</span> on 9 October 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2FPRGOPR%2811%29.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20101129152733/http://perrigo.com/uploadedFiles/Investors/Press_Releases/JBLABPR.pdf">"Official Perrigo Company Press Release"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/JBLABPR.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 November 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Official+Perrigo+Company+Press+Release&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2FJBLABPR.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120314192028/http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/DIBAPR.pdf">"Official Perrigo Company Press Release"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/DIBAPR.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 14 March 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Official+Perrigo+Company+Press+Release&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2FDIBAPR.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110623072008/http://perrigo.com/uploadedFiles/Investors/Press_Releases/UNIPR.pdf">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/UNIPR.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 23 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2FUNIPR.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110715064939/http://www.perrigo.com/uploadedfiles/Investors/Press_Releases/ORION.pdf">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedfiles/Investors/Press_Releases/ORION.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 15 July 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2Fuploadedfiles%2FInvestors%2FPress_Releases%2FORION.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110623064940/http://perrigo.com/uploadedFiles/Investors/Press_Releases/PBMCLS.pdf">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/PBMCLS.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 23 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2FPBMCLS.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110626213156/http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/110119%20Paddle%20PR%20v9%20-%20FINAL%20CHANGES.pdf">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/110119%20Paddle%20PR%20v9%20-%20FINAL%20CHANGES.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 26 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.perrigo.com%2FuploadedFiles%2FInvestors%2FPress_Releases%2F110119%2520Paddle%2520PR%2520v9%2520-%2520FINAL%2520CHANGES.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Sergeant's_Pet_Care_Acquisition-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sergeant's_Pet_Care_Acquisition_31-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://perrigo.investorroom.com/2012-10-01-Perrigo-Closes-Acquisition-Of-Sergeants-Pet-Care-Products">"Perrigo Closes Acquisition Of Sergeant's Pet Care Products"</a>. <i>Perrigo Company</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Perrigo+Company&amp;rft.atitle=Perrigo+Closes+Acquisition+Of+Sergeant%27s+Pet+Care+Products&amp;rft_id=http%3A%2F%2Fperrigo.investorroom.com%2F2012-10-01-Perrigo-Closes-Acquisition-Of-Sergeants-Pet-Care-Products&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Rosemont_acqusition-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rosemont_acqusition_32-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://perrigo.investorroom.com/2013-02-11-Perrigo-Company-Acquires-U.K.-based-Rosemont-Pharmaceuticals-Ltd.-For-Approximately-180-Million-Or-283-Million">"Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Perrigo+Company+Acquires+U.K.-based+Rosemont+Pharmaceuticals+Ltd.+For+Approximately+%C2%A3180+Million+Or+%24283+Million&amp;rft_id=http%3A%2F%2Fperrigo.investorroom.com%2F2013-02-11-Perrigo-Company-Acquires-U.K.-based-Rosemont-Pharmaceuticals-Ltd.-For-Approximately-180-Million-Or-283-Million&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation web">Reuters (29 July 2013). <a rel="nofollow" class="external text" href="https://www.handelsblatt.com/unternehmen/industrie/us-generikakonzern-perrigo-kauft-irische-pharmafirma-elan-/8563244.html">"US-Generikakonzern: Perrigo kauft irische Pharmafirma Elan"</a>. <i>handelsblatt.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=handelsblatt.com&amp;rft.atitle=US-Generikakonzern%3A+Perrigo+kauft+irische+Pharmafirma+Elan&amp;rft.date=2013-07-29&amp;rft.au=Reuters&amp;rft_id=https%3A%2F%2Fwww.handelsblatt.com%2Funternehmen%2Findustrie%2Fus-generikakonzern-perrigo-kauft-irische-pharmafirma-elan-%2F8563244.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.theguardian.com/business/2013/jul/29/us-drugmaker-perrigo-buy-elan">"This page has been removed - News - The Guardian"</a>. <i>the Guardian</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=the+Guardian&amp;rft.atitle=This+page+has+been+removed+-+News+-+The+Guardian&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2013%2Fjul%2F29%2Fus-drugmaker-perrigo-buy-elan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation news">Pogatchnik, Shawn (29 July 2013). <a rel="nofollow" class="external text" href="https://www.bostonglobe.com/business/2013/07/29/perrigo-buy-elan-for-seeks-tax-savings/zefyefdUwJVDLG7ciScqtK/story.html">"Perrigo to buy Elan, reincorporate in Ireland"</a>. <i>Boston Globe</i><span class="reference-accessdate">. Retrieved <span class="nowrap">20 January</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Boston+Globe&amp;rft.atitle=Perrigo+to+buy+Elan%2C+reincorporate+in+Ireland&amp;rft.date=2013-07-29&amp;rft.au=Pogatchnik%2C+Shawn&amp;rft_id=https%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2013%2F07%2F29%2Fperrigo-buy-elan-for-seeks-tax-savings%2FzefyefdUwJVDLG7ciScqtK%2Fstory.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation news">Risser, David (6 November 2014). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-11-06/perrigo-to-buy-omega-pharma-of-belgium-for-4-5-billion.html">"Perrigo to Buy Omega Pharma of Belgium for $4.5 Billion"</a>. <i>Bloomberg</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=Perrigo+to+Buy+Omega+Pharma+of+Belgium+for+%244.5+Billion&amp;rft.date=2014-11-06&amp;rft.aulast=Risser&amp;rft.aufirst=David&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-11-06%2Fperrigo-to-buy-omega-pharma-of-belgium-for-4-5-billion.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.standaard.be/cnt/dmf20141106_01361815">"Belgian newspaper De standaard reports Perrigo to Buy Omega Pharma for €3.6 Billion"</a>. <i>De Standaard</i>. 6 November 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=De+Standaard&amp;rft.atitle=Belgian+newspaper+De+standaard+reports+Perrigo+to+Buy+Omega+Pharma+for+%E2%82%AC3.6+Billion&amp;rft.date=2014-11-06&amp;rft_id=http%3A%2F%2Fwww.standaard.be%2Fcnt%2Fdmf20141106_01361815&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-complete-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-complete_38-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.prnewswire.com/news-releases/perrigo-company-plc-completes-acquisition-of-omega-pharma-invest-nv-creating-a-top-five-global-otc-company-300057595.html">"Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company"</a>. PR Newswire Association LLC. PR Newswire. 30 March 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Perrigo+Company+plc+Completes+Acquisition+Of+Omega+Pharma+Invest+N.V.%2C+Creating+A+Top+Five+Global+OTC+Company&amp;rft.date=2015-03-30&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fperrigo-company-plc-completes-acquisition-of-omega-pharma-invest-nv-creating-a-top-five-global-otc-company-300057595.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/pharma/struggling-perrigo-inks-deal-agreement-for-ga-based-distributor">"Struggling Perrigo inks deal agreement for GA-based distributor - FiercePharma"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Struggling+Perrigo+inks+deal+agreement+for+GA-based+distributor+-+FiercePharma&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fstruggling-perrigo-inks-deal-agreement-for-ga-based-distributor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/perrigo-to-expand-into-adjacent-self-care-category-by-acquiring-ranir-global-holdings-llc-the-leading-global-private-label-supplier-of-oral-self-care-products/">"Perrigo To Expand Into Adjacent Self-Care Category By Acquiring Ranir Global Holdings LLC, The Leading Global Private Label Supplier Of Oral Self-Care Products"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Perrigo+To+Expand+Into+Adjacent+Self-Care+Category+By+Acquiring+Ranir+Global+Holdings+LLC%2C+The+Leading+Global+Private+Label+Supplier+Of+Oral+Self-Care+Products&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fperrigo-to-expand-into-adjacent-self-care-category-by-acquiring-ranir-global-holdings-llc-the-leading-global-private-label-supplier-of-oral-self-care-products%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/perrigo-to-acquire-oral-care-assets-of-high-ridge-brands/">"Perrigo To Acquire Oral Care Assets Of High Ridge Brands"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">25 February</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Perrigo+To+Acquire+Oral+Care+Assets+Of+High+Ridge+Brands&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fperrigo-to-acquire-oral-care-assets-of-high-ridge-brands%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/brief-perrigo-to-acquire-oral-care-asset-idUSASA00EQ3">"BRIEF-Perrigo To Acquire Oral Care Assets Of High Ridge Brands"</a>. <i>Reuters</i>. 24 February 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">19 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=BRIEF-Perrigo+To+Acquire+Oral+Care+Assets+Of+High+Ridge+Brands&amp;rft.date=2020-02-24&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fbrief-perrigo-to-acquire-oral-care-asset-idUSASA00EQ3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/perrigo-to-acquire-oral-care-assets-of-high-ridge-brands-for-113m-57247463">"Perrigo to acquire oral care assets of High Ridge Brands for $113M"</a>. <i>www.spglobal.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">19 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.spglobal.com&amp;rft.atitle=Perrigo+to+acquire+oral+care+assets+of+High+Ridge+Brands+for+%24113M&amp;rft_id=https%3A%2F%2Fwww.spglobal.com%2Fmarketintelligence%2Fen%2Fnews-insights%2Flatest-news-headlines%2Fperrigo-to-acquire-oral-care-assets-of-high-ridge-brands-for-113m-57247463&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation news">Editorial, Reuters. <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-perrigo-company-divestiture/perrigo-board-okays-separation-of-prescription-pharma-business-idUSKBN1KU0F9">"Perrigo board okays separation of prescription pharma business"</a>. <i>U.S</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=U.S.&amp;rft.atitle=Perrigo+board+okays+separation+of+prescription+pharma+business&amp;rft.aulast=Editorial&amp;rft.aufirst=Reuters&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-perrigo-company-divestiture%2Fperrigo-board-okays-separation-of-prescription-pharma-business-idUSKBN1KU0F9&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APerrigo" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Perrigo&amp;action=edit&amp;section=7" title="Edit section: External links" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.perrigo.com">Official website</a></span></span></li>
<li>Business data for Perrigo: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=PRGO">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=PRGO">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=PRGO">SEC filings</a></li></ul></div></li></ul>






</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Perrigo&amp;oldid=946391808">https://en.wikipedia.org/w/index.php?title=Perrigo&amp;oldid=946391808</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Perrigo"
				data-user-name="Sedgedorrit"
				data-user-gender="unknown"
				data-timestamp="1584653654">
				<span>Last edited on 19 March 2020, at 21:34</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Perrigo&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.684","walltime":"0.868","ppvisitednodes":{"value":3547,"limit":1000000},"postexpandincludesize":{"value":220490,"limit":2097152},"templateargumentsize":{"value":4108,"limit":2097152},"expansiondepth":{"value":36,"limit":40},"expensivefunctioncount":{"value":4,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":168701,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  759.992      1 -total"," 88.48%  672.434     17 Template:Clade"," 38.06%  289.255      1 Template:Reflist"," 24.02%  182.572      1 Template:Infobox_company"," 22.11%  168.015      1 Template:Infobox"," 15.33%  116.500     29 Template:Cite_web"," 13.95%  106.044     10 Template:Cite_news","  8.07%   61.297      5 Template:Wikidata","  7.59%   57.693      1 Template:Short_description","  5.72%   43.442      1 Template:Pagetype"]},"scribunto":{"limitreport-timeusage":{"value":"0.361","limit":"10.000"},"limitreport-memusage":{"value":7320773,"limit":52428800}},"cachereport":{"origin":"mw1401","timestamp":"20200416052824","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Perrigo","url":"https:\/\/en.wikipedia.org\/wiki\/Perrigo","sameAs":"http:\/\/www.wikidata.org\/entity\/Q2916497","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q2916497","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2005-11-06T18:20:26Z","dateModified":"2020-03-19T21:34:14Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/f\/f9\/Perrigo_logo.svg","headline":"pharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":125,"wgHostname":"mw1413"});});</script>		</body>
		</html>
		